Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is M  [Clear All Filters]
2016
Zhou JY, Zhang Z, Qian GS. Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic. Cell Death Discov. 2016;2:16055.
Cipriani P, Di Benedetto P, Liakouli V, Giacomelli R. Mesenchymal stem cells transplantation in Systemic Sclerosis: comment on the article by ATJ Maria et al. Arthritis Rheumatol. 2016.
Moravej A, Karimi M-H, Geramizadeh B, Azarpira N, Zarnani A-H, Yaghobi R, Khosravi M, Kalani M, Gharesi-Fard B. Mesenchymal Stem Cells Upregulate the Expression of PD-L1 But Not VDR in Dendritic Cells. Immunol Invest. 2016:1-17.
Li Y, Xu J, Shi W, Chen C, Shao Y, Zhu L, Lu W, Han X. Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice. Stem Cell Res Ther. 2016;7(1):159.
Strueby L, Thébaud B. Mesenchymal Stromal Cell-Based Therapies for Chronic Lung Disease of Prematurity. Am J Perinatol. 2016;33(11):1043-1049.
Mead B, Hill LJ, Blanch RJ, Ward K, Logan A, Berry M, Leadbeater W, Scheven BA. Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma. Cytotherapy. 2016.
Alessio N, Capasso S, Di Bernardo G, Cappabianca S, Casale F, Calarco A, Cipollaro M, Peluso G, Galderisi U. Mesenchymal stromal cells having inactivated RB1 survive following low irradiation and accumulate damaged DNA: hints for side effects following radiotherapy. Cell Cycle. 2016.
Chiossone L, Conte R, Spaggiari GMaria, Serra M, Romei C, Bellora F, Becchetti F, Andaloro A, Moretta L, Bottino C. Mesenchymal stromal cells induce peculiar alternatively activated macrophages capable of dampening both innate and adaptive immune responses. Stem Cells. 2016.
Antonello ZA, Reiff T, Dominguez M. Mesenchymal to epithelial transition during tissue homeostasis and regeneration: Patching up the Drosophila midgut epithelium. Fly (Austin). 2016.
Takaishi M, Tarutani M, Takeda J, Sano S. Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells. PLoS One. 2016;11(6):e0156904.
Goldman O, Valdes VJulian, Ezhkova E, Gouon-Evans V. The mesenchymal transcription factor SNAI-1 instructs human liver specification. Stem Cell Res. 2016;17(1):62-68.
Kyba M. Mesoderm, Cooked Up Fast and Served to Order. Cell Stem Cell. 2016;19(2):146-8.
Rosenholm JMaria, Zhang J, Linden M, Sahlgren C. Mesoporous silica nanoparticles in tissue engineering - a perspective. Nanomedicine (Lond). 2016.
Durfee PN, Lin Y-S, Dunphy DR, Muniz AJ, Butler KS, Humphrey KR, Lokke AJ, Agola JOngudi, Chou SS, Chen I-M, et al. Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells. ACS Nano. 2016.
Liang L, Sun H, Zhang W, Zhang M, Yang X, Kuang R, Zheng H. Meta-Analysis of EMT Datasets Reveals Different Types of EMT. PLoS One. 2016;11(6):e0156839.
Wruck W, Schröter F, Adjaye J. Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsiesand iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Revealsan Association with FOXA1 and FOXA2 Gene Regulatory Networks. J Alzheimers Dis. 2016.
Kumarasingha R, Karpe AV, Preston S, Yeo T-C, Lim DSL, Tu C-L, Luu, ii J, Simpson KJ, Shaw JM, Gasser RB, et al. Metabolic profiling and in vitro assessment of anthelmintic fractions of Picria fel-terrae Lour. Int J Parasitol Drugs Drug Resist. 2016;6(3):171-178.
Mathieu J, Ruohola-Baker H. Metabolic RemodeLIN of Pluripotency. Cell Stem Cell. 2016;19(1):3-4.
DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, et al. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplant. 2016.
Ito K, Ito K. Metabolism and the Control of Cell Fate Decisions and Stem Cell Renewal. Annu Rev Cell Dev Biol. 2016.
Kaneko KJ. Metabolism of Preimplantation Embryo Development: A Bystander or an Active Participant?. Curr Top Dev Biol. 2016;120:259-310.
Derlet A, Rasper T, Choudhury ARoy, Bothur S, Rieger MA, Namgaladze D, Fischer A, Schürmann C, Brandes RP, Tschulena U, et al. Metabolism regulates cellular functions of bone marrow-derived cells used for cardiac therapy. Stem Cells. 2016.
Achuta VSwaroop, Grym H, Putkonen N, Louhivuori V, Kärkkäinen V, Koistinaho J, Roybon L, Castrén ML. Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells in fragile X syndrome. Dev Neurobiol. 2016.
Siney EJ, Holden A, Casselden E, Bulstrode H, Thomas GJ, Willaime-Morawek S. Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells. Mol Neurobiol. 2016.
Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, Massagué J. Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell. 2016;165(1):45-60.

Pages